
Glimtune M 1mg/500mg Tablet SR
Marketer
Fortune Labs
Salt Composition
Glimepiride (1mg) + Metformin (500mg)
Overview Glimtune M 1mg/500mg Tablet SR
Diabex Duo 1mg/500mg Extended-Release Tablets are classified as antidiabetic agents. This dual-action medication treats type 2 diabetes in adults by regulating blood glucose. Diabex Duo should be ingested with food, consistently at the same time daily for optimal efficacy. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuation without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. Remember, this medication complements a comprehensive diabetes management plan incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Commonly, Diabex Duo may cause hypoglycemia (low blood sugar). Learn to identify its symptoms – sweating, dizziness, headache, and tremors – and know how to manage them. Regular meals and readily available glucose sources (e.g., sugary snacks, fruit juice) are essential preventative measures. Alcohol consumption should be minimized due to its potential to exacerbate hypoglycemia. Other possible side effects include altered taste, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain is also a potential consequence. Diabex Duo is contraindicated for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your doctor before commencing treatment. This medication's suitability for pregnant or breastfeeding women requires physician consultation. Regular blood glucose monitoring is necessary, and your doctor may order blood tests to track blood cell counts and liver function.
Uses of Glimtune M 1mg/500mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glimtune M 1mg/500mg Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Glimtune M 1mg/500mg SR Tablets. Ingest the tablets whole; do not crush, chew, or break them. Administer this medication with a meal.
Common Side effects of Glimtune M 1mg/500mg Tablet SR:
- Headache
- Hypoglycemia (low blood glucose level)
- Nausea
- Diarrhea
How to use Glimtune M 1mg/500mg Tablet SR:
Administer this medication precisely as prescribed by your physician, adhering to both dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Consume Glimtune M 1mg/500mg Extended-Release tablets with food.
How Glimtune M 1mg/500mg Tablet SR works:
Glimtune M 1mg/500mg Extended-Release Tablets combine glimepiride and metformin, two distinct antidiabetic agents. Glimepiride, a sulfonylurea, enhances pancreatic insulin secretion to reduce blood sugar. Metformin, a biguanide, acts through a threefold mechanism: decreasing hepatic glucose production, slowing intestinal glucose absorption, and improving insulin responsiveness.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glimtune M 1mg/500mg SR tablets with alcohol is unsafe.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glimtune M 1mg/500mg tablet may pose pregnancy risks. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the advantages against possible dangers prior to prescribing. Physician consultation is advised.
Breast feedingUNSAFE
Prolonged-release Glimtune M 1mg/500mg tablets are contraindicated for breastfeeding mothers. Evidence indicates potential infant toxicity from this medication.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with impaired kidney function should exercise caution when using Glimtune M 1mg/500mg SR tablets, as dose modification may be necessary. Medical advice is essential. Glimtune M 1mg/500mg SR tablets are contraindicated in individuals with severely compromised kidney function. Close monitoring of renal parameters is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glimtune M 1mg/500mg SR tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; the medication is contraindicated in patients with severe hepatic dysfunction.
What if you forget to take Glimtune M 1mg/500mg Tablet SR :
Should you forget a Glimtune M 1mg/500mg SR Tablet dose, administer it immediately. However, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glimtune M 1mg/500mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
